Analyst Research

Report Title Price
Provider: Pechala's Reports
Provider: Reuters Investment Profile
Provider: Thomson Reuters Stock Report
Provider: MacroRisk Analytics/EconomicInvestor

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

TrovaGene Inc Announces Issuance Of Broad MicroRNA Patent

Wednesday, 24 Jul 2013 05:00am EDT 

Trovagene, Inc. announced that the issuance of US patent 8,486,626, 'Methods of detecting cell-free miRNA in urine and blood.' The patent pertains to the detection and quantitation of microRNA (miRNA) using a wide variety of technologies and platforms. MicroRNAs are known to play critical roles in cell development as well as a number of diseases, including cancer. 

Company Quote

0.03 +0.62%
21 Nov 2014